Antineoplastic AgentsBenzamidesMagnetic Resonance Imaging
Dr. Stacie Lynn Stapleton, MD
NPI1205854692
- Publications
- 30
- Clinical trials
- 17
- Industry payments
- $5,016
- Affiliated sites
- 1
- Medical groups
- 3
- Practice address
- 601 5th St S Ste 306 Suite 306, Saint Petersburg, FL 33701
- Practice phone
- Call (727) 767-4170
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
All Children's Specialty Physicians
Multi-specialty group site · Saint Petersburg, Florida
Find Dr. Stapleton's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Stacie Lynn Stapleton is a pediatric hematology and oncology physician in Saint Petersburg, Florida
Dr. Stapleton practices at All Children's Specialty Physicians in Saint Petersburg, Florida.
Dr. Stapleton's NPI, 1205854692, was assigned on July 17, 2006. Dr. Stapleton graduated from Saint Louis University School Of Medicine in 1996. Dr. Stapleton holds Florida license ME98492.
NPI and contact details
- NPI
- 1205854692NPI Registry (opens in a new tab)
- NPI enumeration date
- July 17, 2006
- NPI status
- Active
- Practice phone
- (727) 767-4170
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Stacie Lynn Stapleton practices at All Children's Specialty Physicians in Saint Petersburg, Florida
Dr. Stapleton's primary practice is All Children's Specialty Physicians, at 601 5th St S Ste 306 Suite 306, Saint Petersburg, FL 33701. The practice phone is (727) 767-4170.
- All Children's Specialty Physicians601 5th St S Ste 306 Suite 306, Saint Petersburg, FL 33701Phone(727) 767-4170
Source: Dmand AI Affiliation Data
Dr. Stacie Lynn Stapleton is affiliated with 1 site of care and 3 medical groups
Dr. Stapleton's primary practice is All Children's Specialty Physicians in Saint Petersburg, Florida. The medical group on file is All Children's Specialty Physicians. Dmand AI also links Dr. Stapleton to 2 more medical groups, each named with a free account.
All Children's Specialty PhysiciansPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Stacie Lynn Stapleton's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stapleton practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| All Children's Specialty Physicians | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Stapleton practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Stacie Lynn Stapleton is one of 152 pediatric hematologys and oncology physicians in Florida
Pediatric hematology-oncology is Dr. Stapleton's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Stapleton is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Stapleton's licenses on file in 3 states: Florida, Texas and Louisiana.
Specialties and state licenses
- Pediatric hematology and oncology, FloridaPrimary
- Texas license
- Louisiana license
Pediatric hematologys and oncology physicians near Dr. Stapleton
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
152pediatric hematologys and oncology physicians in Florida18pediatric hematologys and oncology physicians in Saint Petersburg
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Stacie Lynn Stapleton's patients have a median age of 14
Across all payers, Dmand AI patient panel data puts Dr. Stapleton's median patient age at 14, with 52% women.
Dr. Stapleton's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 14
Patient panel by sex, all payers
- Women52%
- Men48%
Source: Dmand AI Patient Panel Data
Dr. Stacie Lynn Stapleton has 30 publications on record
Dmand AI links 30 papers to Dr. Stapleton, published from 2006 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Cerebellar Neoplasms, Medulloblastoma and Antineoplastic Agents. Dr. Stapleton has published most often in Acta Neuropathol Commun. Dr. Stapleton's most frequent co-authors are George Jallo, Chetan Bettegowda, MD, PhD and Ignacio Gonzalez-Gomez, MD.
Papers30
Years published2006 to 2024
Dr. Stapleton's papers by year, 2006 to 2024
Topics Dr. Stapleton writes about most
- Cerebellar Neoplasms
- Medulloblastoma
- Antineoplastic Agents
- Brain Neoplasms
- RNA, Long Noncoding
- Anthracyclines
- Antineoplastic Combined Chemotherapy Protocols
- Area Under Curve
Dr. Stapleton's most frequent co-authors
- George Jallo13 shared papers
- Chetan Bettegowda, MD, PhD4 shared papers
- Ignacio Gonzalez-Gomez, MD4 shared papers
Recent publications by Dr. Stapleton
AdenosineCerebellar NeoplasmsGene Expression Profiling
Brain NeoplasmsCyclin-Dependent Kinase Inhibitor p16Paraneoplastic Syndromes
See who Dr. Stapleton researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Stapleton works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Stacie Lynn Stapleton has worked on 17 clinical trials
Dmand AI links Dr. Stapleton to 17 clinical trials, 9 of them phase 2 studies. 11 are still active or recruiting. Conditions studied include Histiocytosis, Langerhans-Cell, Medulloblastoma and Hepatoblastoma. National Cancer Institute (NCI) sponsors the most, 8.
Clinical trials with Dr. Stapleton by phase
- 1Early phase 1: 1 trial
- 4Phase 1: 4 trials
- 9Phase 2: 9 trials
- 1Phase 3: 1 trial
- 1Phase 4: 1 trial
Conditions in Dr. Stapleton's trials
- Histiocytosis, Langerhans-Cell
- Medulloblastoma
- Hepatoblastoma
- Neuroectodermal Tumors, Primitive
- Central Nervous System Neoplasms
Investigators on the most trials with Dr. Stapleton
- Scott M. Bradfield, MD5 shared trials
- Erin Haag Breese, MD5 shared trials
- Don E. Eslin, MD5 shared trials
Recent clinical trials with Dr. Stapleton
A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG) (opens in a new tab)
Active, not recruitingPhase 2
GlioblastomaAstrocytomaDabrafenib MesylateTrametinib Dimethyl SulfoxideRadiation Therapy
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial (opens in a new tab)
Active, not recruitingPhase 2
Histiocytosis, Langerhans-CellHepatoblastomaSelpercatinib
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (opens in a new tab)
Active, not recruitingPhase 2
PheochromocytomaHistiocytosis, Langerhans-CellTipifarnib
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) (opens in a new tab)
Active, not recruitingPhase 2
Histiocytosis, Langerhans-CellHepatoblastomaIvosidenib
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma (opens in a new tab)
Active, not recruitingPhase 3
Neurofibromatosis 1NeurofibromatosesCarboplatinSelumetinib SulfateVincristine Sulfate
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Stacie Lynn Stapleton received $5,016 in industry payments from 2017 to 2025
CMS Open Payments shows 14 general payments to Dr. Stapleton from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 83% of the total. Alexion Pharmaceuticals, Inc. paid the most, $2,340.
General payments to Dr. Stapleton by program year, 2017 to 2025
General payments to Dr. Stapleton by kind, 2017 to 2025
$5Kin total
- Consulting fees$4,17083%
- Food and beverage$79816%
- Education$481%
Companies that paid Dr. Stapleton the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Stacie Lynn Stapleton graduated from Saint Louis University School Of Medicine
Dr. Stapleton graduated from Saint Louis University School Of Medicine in 1996.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Stacie Lynn Stapleton accepts plans from 6 insurance carriers
Dr. Stapleton is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- Blue Cross Blue Shield of Michigan
Plan types Dr. Stapleton accepts, by number of carriers
- PPO6
- Medicare5
- EPO2
- HMO2
- POS2
Source: Dmand AI Insurance Network Data
Sources for Dr. Stacie Lynn Stapleton's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Stacie Lynn Stapleton
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Stacie Lynn Stapleton's NPI number?
Dr. Stacie Lynn Stapleton's NPI number is 1205854692. It was assigned on July 17, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Stacie Lynn Stapleton?
Dr. Stacie Lynn Stapleton is a pediatric hematology and oncology physician in Saint Petersburg, Florida. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Stacie Lynn Stapleton practice?
Dr. Stapleton practices at 601 5th St S Ste 306 Suite 306, Saint Petersburg, FL 33701. Dr. Stapleton's primary practice is All Children's Specialty Physicians in Saint Petersburg, Florida. Dmand AI also links Dr. Stapleton to 2 medical groups.
What is Dr. Stacie Lynn Stapleton's office phone number?
The practice phone on file for Dr. Stapleton is (727) 767-4170.
What is Dr. Stacie Lynn Stapleton's medical license number?
Dr. Stapleton holds Florida license ME98492, one of the licenses on file in 3 states.
Which states has Dr. Stacie Lynn Stapleton been licensed in?
Dmand AI has state licenses on file for Dr. Stapleton in Florida (2007 to 2027), Texas (2006 to 2007) and Louisiana (1997 to 2004).
What medical group is Dr. Stacie Lynn Stapleton part of?
Dr. Stapleton is linked to All Children's Specialty Physicians. Dmand AI links Dr. Stapleton to 2 more medical groups.
Is Dr. Stacie Lynn Stapleton board certified?
Yes. Dr. Stapleton is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Stacie Lynn Stapleton go to medical school?
Dr. Stapleton graduated from Saint Louis University School Of Medicine in 1996.
Has Dr. Stacie Lynn Stapleton received payments from drug or device companies?
CMS Open Payments shows $5,016 in general payments to Dr. Stapleton from 6 companies from 2017 to 2025. The largest total came from Alexion Pharmaceuticals, Inc.
Show 4 more questionsShow fewer questions
How long has Dr. Stacie Lynn Stapleton been practicing?
Dr. Stapleton graduated from medical school in 1996, 30 years ago.
Does Dr. Stacie Lynn Stapleton do research?
Dmand AI links 30 publications to Dr. Stapleton, published from 2006 to 2024. Dr. Stapleton has worked on 17 clinical trials.
Who does Dr. Stacie Lynn Stapleton publish with?
Dr. Stapleton's most frequent co-authors are George Jallo (13 shared papers), Chetan Bettegowda, MD, PhD (4 shared papers) and Ignacio Gonzalez-Gomez, MD (4 shared papers).
What insurance does Dr. Stacie Lynn Stapleton accept?
Dr. Stapleton is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card